• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers

    2017 closes with record approvals of generics, novel drugs; 2018 begins with reprieves for Teva

    PharmaCompass wishes its readers a very happy new year. We begin the year with an analysis of 2017, when we saw record approval...

    Impressions : 4361

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.